Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries

Journal of Cerebral Blood Flow and Metabolism

Volumn 21, Issue 1, 2001, Pages 77-84

  You, Junping ^a,b   Edvinsson, Lars ^b   Bryan Jr , Robert M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelium; Neuropeptide Y; Nitric oxide; NPY receptor; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; N(G) NITROARGININE METHYL ESTER; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRAIN CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MICROPIPETTE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0035196910     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-200101000-00010     Document Type: Article

References (51)

1. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226
2. Neuropeptide Y family of hormones: Receptor subtypes and antagonists
3. Permissive role of NO in alpha 2-adrenoceptor-mediated dilations in rat cerebral arteries
4. Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery
5. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226
6. Neuropeptide Y: Cerebrovascular innervation and vasomotor effects in the cat
7. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels
8. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries
9. Effects of neuropeptide Y on the cardiovascular system
10. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: Involvement of endothelium generated thromboxane
11. [Leu31, Pro34] neuropeptide Y: A specific Y1 receptor agonist
12. A receptor subtype involved in neuropeptide-Y-induced food intake
13. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue
14. Characterization of vascular neuropeptide Y receptors
15. Immunocytochemical localization of the NPY/PYY Y1 receptor in enteric neurons, endothelial cells, and endocrine-like cells of the rat intestinal tract
16. Inward rectifier potassium channels in the rat middle cerebral artery
17. Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide
18. Modulation of submucosal arteriolar tone by neuropeptide Y Y2 receptors in the guinea-pig small intestine
19. Calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in endothelial cells after long-term stimulation of perivascular nerves
20. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function
21. Corelease of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport
22. Neuropeptide Y and sympathetic neurotransmission
23. Recent developments with neuropeptide Y receptor antagonists
24. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY
25. Neuropeptide Y (NPY): A coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction
26. P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia/reperfusion
27. i in pressurized/perfused cerebral arteries with fura-2
28. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed
29. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV
30. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
31. Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries
32. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation
33. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers
34. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney
35. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein
36. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man
37. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries
38. Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries
39. Specific 1251 neuropeptide Y binding to intact cultured bovine adrenal medulla capillary endothelial cells
40. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: Evidence from benextramine protection studies
41. Blockade of nitric oxide decreases the renal vasodilatory effect of neuropeptide Y in the insulin-treated diabetic rat
42. Neuropeptide Y receptor sub-types, Y1 and Y2
43. Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets?
44. Neuropeptide-Y-ATP interactions at the vascular sympathetic neuroeffector junction
45. Relation between cyclic GMP generation and cerebrovascular reactivity: Modulation by NPY and alpha-trinositol
46. Endothelial-mediated dilations of rat middle cerebral arteries by ATP and ADP
47. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat
48. P2u-receptor mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats
49. Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat
50. Origin and actions of neuropeptide Y in the cardiovascular system
51. Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium